Discover gold's global impact on culture, art and science. Facts, myths and magic.

www.goldipedia.gold.org

Hello, you either have JavaScript turned off or an old version of Adobe's Flash Player. Get the latest Flash player.

Gold

Nanotechnology cancer research gets funding boost > Gold News > World Gold Council, all about gold

 

Nanotechnology cancer research gets funding boost

The news feeds on this site are independently provided by Adfero Limited © and do not represent the views or opinions of the World Gold Council.

Thursday, 28th May 2009 (1283 views)

A charitable foundation established by the entertainment industry in the US has granted $73.6 million (£46.1 million) in funding to develop cancer treatments using nanotechnology.

The money from Stand Up To Cancer has been awarded to five research teams over a period of three years and will see scientists utilise nanotechnology - which often involves gold use - as part of their efforts to find a cure for the disease.

Isolating and analysing tumour cells through the use of nanotechnology is one of the aims of the research, while scientists will also be focusing their efforts on developing methods of "starving" malignant tumours and exploring new breast cancer treatment techniques.

"We urgently need more and better treatments and we need everyone to support the scientists who are working so hard to develop more effective treatments," Laura Ziskin of the Stand Up To Cancer executive leadership council stated.

Nanotechnology is currently being used by a number of cancer researchers around the world, with scientists at the Massachusetts Institute of Technology discovering earlier this month that gold nanorods can help destroy tumours without harming other cells.

 

« Back to Gold News stories

 

Gold News Archive:

 
 
News provided by Adfero Ltd

Search

Goldipedia and the world of gold knowledge.

  • Gold Spot Price
  • Bid: $1150.80
  • Ask: $1151.60
  • Last Update: 22:16 GMT
© 2009 World Gold Council - all rights reserved. Produced and managed by CFP Group.